RecruitingNot applicableNCT00567073
Pompe Pregnancy Sub-Registry
Studying Glycogen storage disease due to acid maltase deficiency, late-onset
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Genzyme, a Sanofi Company
- Principal Investigator
- Study DirectorGenzyme, a Sanofi Company
- Enrollment
- 20 enrolled
- Eligibility
- FEMALE
- Timeline
- 2007 – 2034
Study locations (20)
- Barrow Neurol Group- Site Number : 840087, Phoenix, Arizona, United States
- Emory University School Of Medicine- Site Number : 840060, Atlanta, Georgia, United States
- Indianapolis University School of Medicine- Site Number : 840027, Indianapolis, Indiana, United States
- Spectrum for Health- Site Number : 840019, Grand Rapids, Michigan, United States
- New York University School Of Medicine- Site Number : 840040, New York, New York, United States
- Mt. Sinai School of Medicine- Site Number : 840005, New York, New York, United States
- Duke University Medical Center Genetics Dept- Site Number : 840037, Durham, North Carolina, United States
- LSD Data Registry Site LLC- Site Number : 840094, Dublin, Ohio, United States
- Oregon Health and Science University- Site Number : 840095, Portland, Oregon, United States
- O&O Alpan, LLC- Site Number : 840025, Fairfax, Virginia, United States
- Investigational Site Number : 056001, Ghent, Belgium
- Investigational Site Number : 1910001, Zagreb, Croatia
- Investigational Site Number : 1910002, Zagreb, Croatia
- Investigational Site Number : 2030001, Prague, Czechia
- Investigational Site Number : 380008, Brescia, Italy
- +5 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00567073 on ClinicalTrials.govOther trials for Glycogen storage disease due to acid maltase deficiency, late-onset
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGNANCT06150820A Study About Antibody Levels and Biomarkers in the Blood in People With Late-onset Pompe DiseaseAstellas Gene Therapies
- ACTIVE NOT RECRUITINGPHASE1NCT04174105Gene Transfer Study in Patients With Late Onset Pompe DiseaseAstellas Gene Therapies
See all trials for Glycogen storage disease due to acid maltase deficiency, late-onset →